<DOC>
	<DOCNO>NCT00466479</DOCNO>
	<brief_summary>This study evaluate possible non-intraocular pressure ( IOP ) relate effect alpha-1 agonist brimonidine human subject affect progressive glaucomatous optic neuropathy . Brimonidine proven neuroprotective several pre-clinical animal study .</brief_summary>
	<brief_title>Brimonidine v ALTP Progressing Human Glaucoma</brief_title>
	<detailed_description>Patients open angle glaucoma history relative stability visual field follow 18 month . A visual field measure every 3 month total number n = 6 eligible field end phase . Then , eye show progression field ( i.e . deterioration th eexisting glaucoma ) , randomize receive either 0.2 % brimonidine tartrate eyedrop b.i.d . 360° argon laser trabeculoplasty one session . Either treatment put `` top '' pre-existing anti-glaucoma therapy . Then , 18-month phase plan , sequnece field take pace previous phase . Progression detect ( measure ) acording trend-analysis ( i.e . regression v time single point cluster adjacent point ) .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<criteria>Glaucomatous visual field defect achromatic perimetry ( 24/2 Humphrey full threshold , abnormal GHT CPSD , p &lt; 0.01 ) consider clinically “ unstable ” IOP &lt; 20 mmHg repeat reading 2 medication , Open angle gonioscopy , Glaucomatous optic neuropathy ( HRTII , Moorfields regression analysis ) , Clear lens ( LOCS2 score &lt; C1 , N0 , P0 ) Best correct visual acuity well 0.2 LogMAR ( ETDRS chart ) , No previous bulbar surgery Manifest refraction within – 5 + 2 diopter No comorbidity ( AMD diabetic retinopathy.and negative history neurological disease ) Closed angle Previous bulbar surgery Unstable IOP Unreliable visual field historic data</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>neuroprotection</keyword>
	<keyword>alpha one agonist</keyword>
	<keyword>glaucoma</keyword>
	<keyword>visual field</keyword>
</DOC>